Daniela Galimberti

Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration.

Association of a NOS1 promoter repeat with Alzheimer's disease.

The cornea in Sjogren's syndrome: an in vivo confocal study.

Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.

ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution.

Serum folate concentrations in patients with cortical and subcortical dementias.

Role of VEGF gene variability in longevity: a lesson from the Italian population.

Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis.

Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation.

Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.

Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration.

Corneal involvement in rheumatoid arthritis: an in vivo confocal study.

Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series.

Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.

A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Polymorphisms in the LOC387715/ARMS2 putative gene and the risk for Alzheimer's disease.

Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation.

Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer's disease?

Association study to evaluate the serotonin transporter and apolipoprotein E genes in frontotemporal lobar degeneration in Italy.

Candidate gene analysis of selectin cluster in patients with multiple sclerosis.

Interleukin-6 plasma level increases with age in an Italian elderly population ("The Treviso Longeva"-Trelong-study) with a sex-specific contribution of rs1800795 polymorphism.

CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration.

Study of thyroid hormone receptor alpha gene polymorphisms on Alzheimer's disease.

MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels.

Serotonin transporter gene polymorphic element 5-HTTLPR increases the risk of sporadic Parkinson's disease in Italy.

Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.

The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances.

No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort.

Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease.

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.

Absence of TARDBP gene mutations in an italian series of patients with frontotemporal lobar degeneration.

Alpha1-antichymotrypsin induces TNF-alpha production and NF-kappaB activation in the murine N9 microglial cell line.

Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer's disease.

A study of the association between the ADAM12 and SH3PXD2A (SH3MD1) genes and Alzheimer's disease.

Candidate gene analysis of semaphorins in patients with Alzheimer's disease.

Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes.

Inflammation in neurodegenerative disorders: friend or foe?

FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration.

GRN variability contributes to sporadic frontotemporal lobar degeneration.

The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment.

Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population.

Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches.

Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline.

In vivo confocal microscopy of the ocular surface.

Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis.

Failure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patients.

Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.

Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration?

The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.

Founder effect and estimation of the age of the Progranulin Thr272fs mutation in 14 Italian pedigrees with frontotemporal lobar degeneration.

Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population.

Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease.

BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease.

In vivo confocal microscopy of meibomian glands in Sjögren's syndrome.

Inflammation and oxidative damage in Alzheimer's disease: friend or foe?

Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations.

Alzheimer's disease: from pathogenesis to disease-modifying approaches.

Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred.

An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.

Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid.

Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects.

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer's disease: the VITA and Milano studies.

In vivo confocal microscopy of conjunctival roundish bright objects: young, older, and Sjögren subjects.

GSK3β genetic variability in patients with Multiple Sclerosis.

APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias.

Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration.

A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia.

Lack of Association between the GPR3 Gene and the Risk for Alzheimer's Disease.

Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients.

A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk.

Progress in Alzheimer's disease.

Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis.

Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis.

Disease-modifying treatments for Alzheimer's disease.

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.

Heterosexual pedophilia in a frontotemporal dementia patient with a mutation in the progranulin gene.

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis.

Cerebrospinal fluid biomarkers in Progranulin mutations carriers.

From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder.

The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype.

MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers.

Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study.

Sciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathy.

A functional variant in ERAP1 predisposes to multiple sclerosis.

Behavioral genetics of neurodegenerative disorders.

Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment.

Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII.

Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia.

Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer's disease patients.

Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.

Clinical phenotypes and genetic biomarkers of FTLD.

Frontotemporal lobar degeneration: current knowledge and future challenges.

Genetics of frontotemporal lobar degeneration.

Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations.

Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration.

The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.

Progress in multiple sclerosis research in the last year.

Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration.

Epigenetic modulation of BDNF gene in patients with major depressive disorder.

Investigation of C9orf72 in 4 Neurodegenerative Disorders.

SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

The impact of osteopontin gene variations on multiple sclerosis development and progression.

Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia.

Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.

A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation.

Does vascular burden contribute to the progression of mild cognitive impairment to dementia?

MicroRNAs as active players in the pathogenesis of multiple sclerosis.

Immunotherapy against amyloid pathology in Alzheimer's disease.

Inflammation in dry eye associated with rheumatoid arthritis: cytokine and in vivo confocal microscopy study.

Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.

A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.

Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study.

Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease.

Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9.

Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis.

Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation.

GRN Thr272fs clinical heterogeneity: a case with atypical late onset presenting with a dementia with Lewy bodies phenotype.

Progress in Alzheimer's disease research in the last year.

Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia.

Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.

Estimating the inheritance of frontotemporal lobar degeneration in the Italian population.

Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma.

The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.

Dementia: not only Alzheimer's disease, an eye on frontotemporal dementia.

Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism.

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions: frequency in a cohort of geriatric non-demented subjects.

An emerging role for long non-coding RNA dysregulation in neurological disorders.

Heterozygous TREM2 mutations in frontotemporal dementia.

Brain temperature in multiple sclerosis.

Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.

Physical activity reduces the risk of dementia in mild cognitive impairment subjects: a cohort study.

Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion of melphalan.

C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder.

Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.

Disease-modifying drugs in Alzheimer's disease.

C9ORF72 repeat expansion not detected in patients with multiple sclerosis.

C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia.

Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder.

Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis.

Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis.

Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion: a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits.

Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.

No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.

Clinical and MRI correlates of disease progression in a case of nonfluent/agrammatic variant of primary progressive aphasia due to progranulin (GRN) Cys157LysfsX97 mutation.

Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients.

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.

Frontotemporal dementia and its subtypes: a genome-wide association study.

Is HCRTR2 a genetic risk factor for Alzheimer's disease?

Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients.

Possible association between SNAP-25 single nucleotide polymorphisms and alterations of categorical fluency and functional MRI parameters in Alzheimer's disease.

Circulating miRNAs as potential biomarkers in Alzheimer's disease.

Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions.

Transmembrane protein 106B gene (TMEM106B) variability and influence on progranulin plasma levels in patients with Alzheimer's disease.

Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders.

Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.

The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia.

Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia.

CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis.

Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations.

TREM2 regulates microglial cell activation in response to demyelination in vivo.

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism.

The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients.

Mutation analysis of CHCHD10 in different neurodegenerative diseases.

SORL1 Gene is Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

MRI helps depict clinically undetectable risk factors in advanced stage retinoblastomas.

Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis.

Idalopirdine as a treatment for Alzheimer's disease.

Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?

A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia.

Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.

Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy.

Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway?

Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.

Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.

PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.

Emerging amyloid disease-modifying drugs for Alzheimer's disease.

Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation.

Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.

Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.

Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease.

Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease.

Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.

Body Mass Index Predicts Progression of Mild Cognitive Impairment to Dementia.

Transcranial Direct Current Stimulation Modulates Cortical Neuronal Activity in Alzheimer's Disease.

CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.

Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations.

Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.

Old and new acetylcholinesterase inhibitors for Alzheimer's disease.

Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.

Neurofilament light chain: a biomarker for genetic frontotemporal dementia.

Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.

Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.

Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis.